Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 90

1.

Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.

Carulla P, Bribián A, Rangel A, Gavín R, Ferrer I, Caelles C, Del Río JA, Llorens F.

Mol Biol Cell. 2011 Sep;22(17):3041-54. doi: 10.1091/mbc.E11-04-0321. Epub 2011 Jul 14.

2.

Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

Quigley HA, Cone FE, Gelman SE, Yang Z, Son JL, Oglesby EN, Pease ME, Zack DJ.

Exp Eye Res. 2011 Apr;92(4):299-305. doi: 10.1016/j.exer.2011.01.006. Epub 2011 Jan 25.

3.

JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction.

Yu J, Novgorodov SA, Chudakova D, Zhu H, Bielawska A, Bielawski J, Obeid LM, Kindy MS, Gudz TI.

J Biol Chem. 2007 Aug 31;282(35):25940-9. Epub 2007 Jul 3.

4.

Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.

Genabai NK, Ahmad S, Zhang Z, Jiang X, Gabaldon CA, Gangwani L.

Hum Mol Genet. 2015 Dec 15;24(24):6986-7004. doi: 10.1093/hmg/ddv401. Epub 2015 Sep 30.

5.

Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Chintala SK, Putris N, Geno M.

Invest Ophthalmol Vis Sci. 2015 Jan 6;56(1):505-14. doi: 10.1167/iovs.14-15539.

6.

JNK3 perpetuates metabolic stress induced by Aβ peptides.

Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ, Walton JC, Nagahara AH, Lu KP, Nelson RJ, Tuszynski MH, Huang K.

Neuron. 2012 Sep 6;75(5):824-37. doi: 10.1016/j.neuron.2012.06.024.

7.

JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death.

Fernandes KA, Harder JM, Fornarola LB, Freeman RS, Clark AF, Pang IH, John SW, Libby RT.

Neurobiol Dis. 2012 May;46(2):393-401. doi: 10.1016/j.nbd.2012.02.003. Epub 2012 Feb 14.

8.

c-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice.

Yoshimura K, Ueno M, Lee S, Nakamura Y, Sato A, Yoshimura K, Kishima H, Yoshimine T, Yamashita T.

Neurosci Res. 2011 Nov;71(3):266-77. doi: 10.1016/j.neures.2011.07.1830. Epub 2011 Jul 28.

PMID:
21824499
9.

Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.

Lomoio S, Scherini E, Necchi D.

Brain Res. 2009 Nov 10;1297:198-206. doi: 10.1016/j.brainres.2009.08.052. Epub 2009 Aug 21.

PMID:
19703431
10.

JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.

Ries V, Silva RM, Oo TF, Cheng HC, Rzhetskaya M, Kholodilov N, Flavell RA, Kuan CY, Rakic P, Burke RE.

J Neurochem. 2008 Dec;107(6):1578-88. doi: 10.1111/j.1471-4159.2008.05713.x. Epub 2008 Nov 5.

11.

ApoE receptor 2 controls neuronal survival in the adult brain.

Beffert U, Nematollah Farsian F, Masiulis I, Hammer RE, Yoon SO, Giehl KM, Herz J.

Curr Biol. 2006 Dec 19;16(24):2446-52.

12.

Sunday Driver links axonal transport to damage signaling.

Cavalli V, Kujala P, Klumperman J, Goldstein LS.

J Cell Biol. 2005 Feb 28;168(5):775-87.

13.

Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform.

Casanova E, Garate C, Ovalle S, Calvo P, Chinchetru MA.

Neuroreport. 1996 May 17;7(7):1320-4.

PMID:
8817558
14.

Developmental expression in the mouse nervous system of the p493F12 SAP kinase.

Martin JH, Mohit AA, Miller CA.

Brain Res Mol Brain Res. 1996 Jan;35(1-2):47-57.

PMID:
8717339
15.

Ontogeny of neuropsin mRNA expression in the mouse brain.

Suzuki J, Yoshida S, Chen ZL, Momota Y, Kato K, Hirata A, Shiosaka S.

Neurosci Res. 1995 Nov;23(4):345-51.

PMID:
8602273
16.

EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.

Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon SO, Segarra M, Eberhart CG, Acker-Palmer A, Tosato G.

Nat Commun. 2015 Mar 26;6:6576. doi: 10.1038/ncomms7576.

17.

Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells.

Wagley Y, Hwang CK, Lin HY, Kam AF, Law PY, Loh HH, Wei LN.

Biochim Biophys Acta. 2013 Jun;1833(6):1476-88. doi: 10.1016/j.bbamcr.2013.02.017. Epub 2013 Feb 26.

18.

Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes.

Reinecke K, Herdegen T, Eminel S, Aldenhoff JB, Schiffelholz T.

Behav Brain Res. 2013 May 15;245:88-95. doi: 10.1016/j.bbr.2013.02.013. Epub 2013 Feb 18.

PMID:
23428746
19.

Activity of all JNK isoforms contributes to neurite growth in spiral ganglion neurons.

Atkinson PJ, Cho CH, Hansen MR, Green SH.

Hear Res. 2011 Aug;278(1-2):77-85. doi: 10.1016/j.heares.2011.04.011. Epub 2011 May 1.

20.

Transcriptional regulation and activation of the mitogen-activated protein kinase pathway after Japanese encephalitis virus infection in neuroblastoma cells.

Gupta N, Bhaskar AS, Lakshmana Rao PV.

FEMS Immunol Med Microbiol. 2011 Jun;62(1):110-21. doi: 10.1111/j.1574-695X.2011.00792.x. Epub 2011 Mar 8.

Supplemental Content

Support Center